President Trump has tapped Dr. Nicole Saphier, a radiologist and former Fox News medical contributor, to be the next surgeon general, his third nominee for the role that serves as the nations doctor and leads public health messaging. Saphier, who directs breast imaging at Memorial Sloan Kettering Monmouth, follows two earlier nominees: Dr. Janette Nesheiwat, whose nomination was withdrawn amid credential questions, and Dr. Casey Means, whose bid failed after opposition from key senators.
Trump praised Saphier on social media as a strong communicator and blamed Sen. Bill Cassidy, chair of the Senate Health, Education, Labor and Pensions Committee, for the collapse of Means nomination. Senators Susan Collins and Lisa Murkowski also opposed Means, and GOP HELP members had concluded Means lacked the votes needed to advance.
Observers say Saphier may face an easier path with many Republican lawmakers than Means did. Her clinical role at a major academic center and high-profile media experience are seen as assets for a post that emphasizes public messaging. David Mansdoerfer, a former HHS deputy assistant secretary, notes she is aligned with core Republican priorities such as pro-life positions and chronic disease prevention and that her communication style appeals to suburban voters targeted by the Make American Healthy Again movement.
Former Surgeon General Jerome Adams and Georges Benjamin, CEO of the American Public Health Association, have called her a reasonable candidate, citing her clinical credentials and temperament. Adams said he expects Saphier to win respect from the medical community, the public, and the administration and predicted she could be confirmed.
At the same time, public health leaders warn that Saphier s background as a cancer specialist, focused on individual diagnosis and treatment, may limit her perspective on population-level determinants of health. They stress that a surgeon general must address broad influences on health such as nutrition assistance, economic conditions, environmental hazards, and community-level prevention strategies. Richard Carmona, a former surgeon general, emphasized the need for demonstrated leadership in public health, experience with population health issues, and credibility to speak for the United States during health emergencies domestically and internationally.
Saphier s public profile extends beyond clinical work. She has hosted media programs, produced a podcast, authored a 2020 book titled Make America Healthy Again, and launched a commercial supplement line. Those entrepreneurial activities and past public statements are likely to draw scrutiny during confirmation.
Vaccine policy is expected to be a central line of questioning. The administration s vaccine approach has been controversial, and Saphier s past comments mix critique and caution. She has criticized linking vaccines to autism and called for research into genetic and environmental causes rather than pursuing unproven associations. At the same time she has suggested public health agencies could be less stringent about some childhood vaccine schedules, specifically citing hepatitis B and COVID-19 vaccines for children, and has voiced opposition to mandates while saying she is not anti-vaccine. Those nuanced positions mirror the debates that defeated Means and will likely be explored by senators.
The HELP Committee will vet Saphier s qualifications, views on vaccines and public health priorities, and any past media or commercial activities. Her confirmation prospects depend on securing support from committee Republicans, including moderates, as well as enough votes to reach the full Senate.
In short, Saphier brings clinical experience, communication skills, and alignment with several Republican priorities, all of which strengthen her candidacy compared with the previous nominee. But questions about her public health outlook, past commentary, commercial interests, and vaccine stances mean she will face rigorous questioning, and her ability to build a bipartisan coalition will determine whether she can win confirmation.